securities fraud

Class action lawsuit filed against REGENXBIO alleging false statements about RGX-111 gene therapy. Covers investors from Feb 2022 to Jan 2026; lead plaintiff deadline April 14.

Class action filed against Enphase Energy alleging inventory misstatement and 25D Tax Credit disclosure failures. Lead plaintiff deadline April 20, 2026.

Eos Energy faces class action lawsuit after revenue missed guidance by $36-46M, stock fell 39.4% following allegations of undisclosed production delays.

Law Offices of Howard G. Smith filed securities fraud class actions against $SDM, $BRBR, $METC, and $CLEUF, alleging market manipulation and misrepresentation. Lead plaintiff deadline: late March 2026.

NuScale Power faces class action lawsuit alleging it misrepresented partner ENTRA1's nuclear experience and failed to disclose material partnership risks to investors.

$PMI stock crashed 70% after investigations revealed illicit social media promotion scheme; shareholders urged to join securities fraud lawsuit with April 3, 2026 deadline.

Class action lawsuit filed against Kyndryl Holdings alleging false financial statements and internal control failures from August 2024 to February 2026. Lead plaintiff deadline April 13, 2026.

Navan stock plunges 63% following securities fraud allegations over undisclosed $95M sales expense spike and CFO departure post-IPO.

Oracle faces class action lawsuit alleging undisclosed AI infrastructure costs and revenue mismatches. Stock declined following missed earnings, delayed data centers, and partner withdrawal.

PayPal shareholders can file claims in securities fraud class action alleging material misstatements about Branded Checkout. Stock plummeted 20.3% following surprise CEO departure and weak earnings.

Bath & Body Works faces class action lawsuit alleging failure to disclose that marketing strategy wasn't driving customer growth. Stock fell 24.8% after November miss.

Schall Law Firm seeks Vistagen investors in class action over alleged false statements regarding fasedienol drug candidate's Phase 3 trial prospects.

GoDaddy stock fell 14% to $79.14 after disappointing Q4 results, weak 2026 guidance, and a securities fraud investigation announcement by the Portnoy Law Firm.

DJS Law Group files class action against $FBRT for allegedly overstating dividend prospects and misleading shareholders about $0.355 quarterly distributions.

Class action lawsuit filed against PayPal for allegedly misleading investors. Stock fell over 20% after disappointing Q4 2025 earnings and guidance withdrawal.

Alight stock crashed 38.2% after disappointing Q4 2025 results, prompting a securities fraud investigation by The Rosen Law Firm over alleged misleading disclosures.

Vital Farms stock plummeted 10.8% after disappointing earnings, triggering securities litigation investigation by Rosen Law Firm into alleged misleading disclosures.

Elauwit Connection faces securities investigation after restating financials due to revenue recognition errors in network construction projects, triggering a 6.8% stock decline.

Class action suits filed against Ultragenyx and Mereo BioPharma following failed Phase III trials for setrusumab, with stock prices crashing 42.32% and 87.7% respectively.

Class actions filed against BlackRock TCP and Plug Power over alleged disclosure failures—BlackRock TCP faces NAV understatement claims following 19% decline; Plug Power accused of overstating DOE funding prospects.